Key facts
- This page summarizes Robert J. Polzer's Form 4 filing for Zoetis Inc. (ZTS).
- 3 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2023, 17:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents performance award units with a three-year performance period covering 2020-2022 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 11, 2023, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F2
Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.
Footnote F3
Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 11, 2023 subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F4
Not applicable.
Footnote F5
Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F6
Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
Footnote F7
One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F8
Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). RSUs vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Footnote F9
Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject toearlier vesting and settlement upon certain specific events.
Footnote F10
The RSUs vest as follows: 282.3532 RSUs will vest on February 11, 2023; 252.3747 will vest on February 10, 2024; and 1,396.0802 RSUs will vest on February 8, 2025.
Footnote F11
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
Footnote F12
One-third of each option will vest on the first, second and third anniversaries of the date of grant.
Footnote F13
Each option expires on the tenth anniversary of the date of grant.
Footnote F14
Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
Footnote F15
1,179 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.
Footnote F16
Each option vests on the third anniversary of the date of grant.